Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "daily"

482 News Found

Eli Lilly unveils $4.5 bn Indiana expansion
News | May 07, 2026

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies


MSD launches cervical cancer awareness campaign with Madhuri Dixit Nene
News | May 06, 2026

MSD launches cervical cancer awareness campaign with Madhuri Dixit Nene

The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness


Silent cough, deadly risk: Doctors warn of hidden asthma surge amid rising pollution
News | May 05, 2026

Silent cough, deadly risk: Doctors warn of hidden asthma surge amid rising pollution

Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses


India unveils first-ever national framework to tackle childhood diabetes
Policy | May 04, 2026

India unveils first-ever national framework to tackle childhood diabetes

New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system


Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive
News | May 04, 2026

Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive

The initiative pairs consumer engagement with a public health message about prevention and early detection


Merck posts mixed Q1 2026 results as blockbuster drugs drive growth
News | May 02, 2026

Merck posts mixed Q1 2026 results as blockbuster drugs drive growth

But acquisition charges drag earnings into loss


Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine


Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials
News | May 01, 2026

Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials

The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations


Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Clinical Trials | April 30, 2026

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026